MBIO
MBIO
NASDAQ · Biotechnology

Mustang Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.70
+0.00 (+0.34%)
As of Jun 30, 10:58 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,371.5% upside
Low Target $6.34
Average Target $10.33
High Target $12.82
Current Price $0.70
Current
$0.70
Target
$10.33
$6.34 $10.33 avg $12.82
Scenario Analysis
Bear Case
$6.34
803.1%
Low target
Base Case
$10.33
+1,371.5%
Avg target
Bull Case
$12.82
+1,726.2%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$7.00
-90.0% from high
52-Week Low
$0.53
+32.3% from low
Target vs 52W High
$10.33
+47.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%